Do analysts prefer OKLO or LTBR?

Oklo currently has a consensus price target of $88.00, indicating a potential upside of 126.01%. Given Oklo's stronger consensus rating and higher possible upside, research analysts clearly believe Oklo is more favorable than Lightbridge. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oklo 1 Sell rating(s) 10 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.52 Lightbridge 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, OKLO or LTBR?

Oklo is trading at a lower price-to-earnings ratio than Lightbridge, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Oklo N/A N/A -$105.66M -$0.84 N/A Lightbridge N/A N/A -$19.58M -$0.77 N/A

Is OKLO or LTBR more profitable?

Oklo's return on equity of -8.57% beat Lightbridge's return on equity. Company Net Margins Return on Equity Return on Assets Oklo N/A -8.57% -8.30% Lightbridge N/A -12.59% -12.50%

Does the media favor OKLO or LTBR?

In the previous week, Oklo had 20 more articles in the media than Lightbridge. MarketBeat recorded 24 mentions for Oklo and 4 mentions for Lightbridge. Oklo's average media sentiment score of 0.77 beat Lightbridge's score of 0.00 indicating that Oklo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oklo 12 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Lightbridge 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate CRTO or LTBR?

Criteo presently has a consensus price target of $27.70, suggesting a potential upside of 26.95%. Given Criteo's stronger consensus rating and higher probable upside, research analysts plainly believe Criteo is more favorable than Lightbridge. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Criteo 1 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50 Lightbridge 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, CRTO or LTBR?

Criteo has higher revenue and earnings than Lightbridge. Lightbridge is trading at a lower price-to-earnings ratio than Criteo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Criteo $1.94B 0.56 $144.60M $2.14 10.20 Lightbridge N/A N/A -$19.58M -$0.77 N/A

Is CRTO or LTBR more profitable?

Criteo has a net margin of 6.06% compared to Lightbridge's net margin of 0.00%. Criteo's return on equity of 14.98% beat Lightbridge's return on equity. Company Net Margins Return on Equity Return on Assets Criteo 6.06% 14.98% 8.25% Lightbridge N/A -12.59% -12.50%

Does the media prefer CRTO or LTBR?

In the previous week, Criteo had 2 more articles in the media than Lightbridge. MarketBeat recorded 6 mentions for Criteo and 4 mentions for Lightbridge. Criteo's average media sentiment score of 0.65 beat Lightbridge's score of 0.00 indicating that Criteo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Criteo 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lightbridge 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate LTBR or GDRX?

GoodRx has a consensus price target of $3.81, indicating a potential upside of 24.19%. Given GoodRx's stronger consensus rating and higher probable upside, analysts clearly believe GoodRx is more favorable than Lightbridge. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lightbridge 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 GoodRx 3 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.13

Which has better earnings & valuation, LTBR or GDRX?

GoodRx has higher revenue and earnings than Lightbridge. Lightbridge is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lightbridge N/A N/A -$19.58M -$0.77 N/A GoodRx $796.85M 1.32 $30.44M $0.06 51.17

Is LTBR or GDRX more profitable?

GoodRx has a net margin of 2.61% compared to Lightbridge's net margin of 0.00%. GoodRx's return on equity of 7.90% beat Lightbridge's return on equity. Company Net Margins Return on Equity Return on Assets Lightbridge N/A -12.59% -12.50% GoodRx 2.61% 7.90% 3.23%

Does the media refer more to LTBR or GDRX?

In the previous week, Lightbridge had 3 more articles in the media than GoodRx. MarketBeat recorded 4 mentions for Lightbridge and 1 mentions for GoodRx. Lightbridge's average media sentiment score of 0.00 equaled GoodRx'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lightbridge 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GoodRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer NUTX or LTBR?

Nutex Health currently has a consensus price target of $243.33, suggesting a potential upside of 65.05%. Given Nutex Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Nutex Health is more favorable than Lightbridge. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nutex Health 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Lightbridge 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor NUTX or LTBR?

In the previous week, Lightbridge had 3 more articles in the media than Nutex Health. MarketBeat recorded 4 mentions for Lightbridge and 1 mentions for Nutex Health. Nutex Health's average media sentiment score of 1.62 beat Lightbridge's score of 0.00 indicating that Nutex Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nutex Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Lightbridge 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer EEX or LTBR?

Emerald currently has a consensus price target of $5.03, indicating a potential downside of 0.18%. Given Emerald's stronger consensus rating and higher possible upside, equities research analysts clearly believe Emerald is more favorable than Lightbridge. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Emerald 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Lightbridge 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is EEX or LTBR more profitable?

Lightbridge has a net margin of 0.00% compared to Emerald's net margin of -8.24%. Emerald's return on equity of -10.81% beat Lightbridge's return on equity. Company Net Margins Return on Equity Return on Assets Emerald -8.24% -10.81% -3.18% Lightbridge N/A -12.59% -12.50%

Does the media prefer EEX or LTBR?

In the previous week, Lightbridge had 3 more articles in the media than Emerald. MarketBeat recorded 4 mentions for Lightbridge and 1 mentions for Emerald. Emerald's average media sentiment score of 0.00 equaled Lightbridge'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Emerald 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lightbridge 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Lightbridge (LTBR) Competitors

$8.24 0.00 (0.00%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$8.15 -0.09 (-1.09%)

As of 07/31/2026 07:35 PM Eastern

Compare

LTBR vs. OKLO, CRTO, GDRX, NUTX, and EEX

Should you buy Lightbridge stock or one of its competitors? MarketBeat compares Lightbridge with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Lightbridge include Oklo (OKLO), Criteo (CRTO), GoodRx (GDRX), Nutex Health (NUTX), and Emerald (EEX).

How does Lightbridge compare to Oklo?

Oklo (NYSE:OKLO) and Lightbridge (NASDAQ:LTBR) are related companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.

Oklo is trading at a lower price-to-earnings ratio than Lightbridge, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oklo	N/A	N/A	-$105.66M	-$0.84	N/A
Lightbridge	N/A	N/A	-$19.58M	-$0.77	N/A

85.0% of Oklo shares are held by institutional investors. Comparatively, 9.1% of Lightbridge shares are held by institutional investors. 12.7% of Oklo shares are held by company insiders. Comparatively, 5.4% of Lightbridge shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Oklo's return on equity of -8.57% beat Lightbridge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oklo	N/A	-8.57%	-8.30%
Lightbridge	N/A	-12.59%	-12.50%

In the previous week, Oklo had 20 more articles in the media than Lightbridge. MarketBeat recorded 24 mentions for Oklo and 4 mentions for Lightbridge. Oklo's average media sentiment score of 0.77 beat Lightbridge's score of 0.00 indicating that Oklo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oklo	12 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Lightbridge	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Oklo has a beta of 1.17, meaning that its stock price is 17% more volatile than the broader market. Comparatively, Lightbridge has a beta of 2.14, meaning that its stock price is 114% more volatile than the broader market.

Oklo currently has a consensus price target of $88.00, indicating a potential upside of 126.01%. Given Oklo's stronger consensus rating and higher possible upside, research analysts clearly believe Oklo is more favorable than Lightbridge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oklo	1 Sell rating(s)	10 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.52
Lightbridge	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Oklo beats Lightbridge on 10 of the 14 factors compared between the two stocks.

How does Lightbridge compare to Criteo?

Criteo (NASDAQ:CRTO) and Lightbridge (NASDAQ:LTBR) are related small-cap companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

Criteo presently has a consensus price target of $27.70, suggesting a potential upside of 26.95%. Given Criteo's stronger consensus rating and higher probable upside, research analysts plainly believe Criteo is more favorable than Lightbridge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Criteo	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Lightbridge	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Criteo has a beta of 0.29, indicating that its stock price is 71% less volatile than the broader market. Comparatively, Lightbridge has a beta of 2.14, indicating that its stock price is 114% more volatile than the broader market.

Criteo has higher revenue and earnings than Lightbridge. Lightbridge is trading at a lower price-to-earnings ratio than Criteo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Criteo	$1.94B	0.56	$144.60M	$2.14	10.20
Lightbridge	N/A	N/A	-$19.58M	-$0.77	N/A

Criteo has a net margin of 6.06% compared to Lightbridge's net margin of 0.00%. Criteo's return on equity of 14.98% beat Lightbridge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Criteo	6.06%	14.98%	8.25%
Lightbridge	N/A	-12.59%	-12.50%

94.3% of Criteo shares are owned by institutional investors. Comparatively, 9.1% of Lightbridge shares are owned by institutional investors. 1.5% of Criteo shares are owned by insiders. Comparatively, 5.4% of Lightbridge shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Criteo had 2 more articles in the media than Lightbridge. MarketBeat recorded 6 mentions for Criteo and 4 mentions for Lightbridge. Criteo's average media sentiment score of 0.65 beat Lightbridge's score of 0.00 indicating that Criteo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Criteo	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lightbridge	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Criteo beats Lightbridge on 13 of the 15 factors compared between the two stocks.

How does Lightbridge compare to GoodRx?

Lightbridge (NASDAQ:LTBR) and GoodRx (NASDAQ:GDRX) are related small-cap companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, dividends, risk, institutional ownership and earnings.

GoodRx has higher revenue and earnings than Lightbridge. Lightbridge is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lightbridge	N/A	N/A	-$19.58M	-$0.77	N/A
GoodRx	$796.85M	1.32	$30.44M	$0.06	51.17

9.1% of Lightbridge shares are held by institutional investors. Comparatively, 63.8% of GoodRx shares are held by institutional investors. 5.4% of Lightbridge shares are held by insiders. Comparatively, 5.9% of GoodRx shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

GoodRx has a net margin of 2.61% compared to Lightbridge's net margin of 0.00%. GoodRx's return on equity of 7.90% beat Lightbridge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lightbridge	N/A	-12.59%	-12.50%
GoodRx	2.61%	7.90%	3.23%

In the previous week, Lightbridge had 3 more articles in the media than GoodRx. MarketBeat recorded 4 mentions for Lightbridge and 1 mentions for GoodRx. Lightbridge's average media sentiment score of 0.00 equaled GoodRx'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lightbridge	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
GoodRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Lightbridge has a beta of 2.14, meaning that its stock price is 114% more volatile than the broader market. Comparatively, GoodRx has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

GoodRx has a consensus price target of $3.81, indicating a potential upside of 24.19%. Given GoodRx's stronger consensus rating and higher probable upside, analysts clearly believe GoodRx is more favorable than Lightbridge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lightbridge	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
GoodRx	3 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.13

Summary

GoodRx beats Lightbridge on 12 of the 14 factors compared between the two stocks.

How does Lightbridge compare to Nutex Health?

Nutex Health (NASDAQ:NUTX) and Lightbridge (NASDAQ:LTBR) are related small-cap companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

Nutex Health has a net margin of 10.95% compared to Lightbridge's net margin of 0.00%. Nutex Health's return on equity of 23.50% beat Lightbridge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutex Health	10.95%	23.50%	10.47%
Lightbridge	N/A	-12.59%	-12.50%

Nutex Health currently has a consensus price target of $243.33, suggesting a potential upside of 65.05%. Given Nutex Health's stronger consensus rating and higher probable upside, equities analysts plainly believe Nutex Health is more favorable than Lightbridge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Lightbridge	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Lightbridge had 3 more articles in the media than Nutex Health. MarketBeat recorded 4 mentions for Lightbridge and 1 mentions for Nutex Health. Nutex Health's average media sentiment score of 1.62 beat Lightbridge's score of 0.00 indicating that Nutex Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nutex Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Lightbridge	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Nutex Health has a beta of 0.24, indicating that its stock price is 76% less volatile than the broader market. Comparatively, Lightbridge has a beta of 2.14, indicating that its stock price is 114% more volatile than the broader market.

Nutex Health has higher revenue and earnings than Lightbridge. Lightbridge is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutex Health	$875.26M	1.16	$70.79M	$12.94	11.39
Lightbridge	N/A	N/A	-$19.58M	-$0.77	N/A

5.3% of Nutex Health shares are held by institutional investors. Comparatively, 9.1% of Lightbridge shares are held by institutional investors. 44.7% of Nutex Health shares are held by company insiders. Comparatively, 5.4% of Lightbridge shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Nutex Health beats Lightbridge on 12 of the 15 factors compared between the two stocks.

How does Lightbridge compare to Emerald?

Emerald (NYSE:EEX) and Lightbridge (NASDAQ:LTBR) are related small-cap companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment.

Emerald currently has a consensus price target of $5.03, indicating a potential downside of 0.18%. Given Emerald's stronger consensus rating and higher possible upside, equities research analysts clearly believe Emerald is more favorable than Lightbridge.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Emerald	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Lightbridge	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Lightbridge has a net margin of 0.00% compared to Emerald's net margin of -8.24%. Emerald's return on equity of -10.81% beat Lightbridge's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Emerald	-8.24%	-10.81%	-3.18%
Lightbridge	N/A	-12.59%	-12.50%

In the previous week, Lightbridge had 3 more articles in the media than Emerald. MarketBeat recorded 4 mentions for Lightbridge and 1 mentions for Emerald. Emerald's average media sentiment score of 0.00 equaled Lightbridge'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Emerald	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lightbridge	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

14.9% of Emerald shares are owned by institutional investors. Comparatively, 9.1% of Lightbridge shares are owned by institutional investors. 5.3% of Emerald shares are owned by insiders. Comparatively, 5.4% of Lightbridge shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Lightbridge has lower revenue, but higher earnings than Emerald. Emerald is trading at a lower price-to-earnings ratio than Lightbridge, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Emerald	$471.10M	2.12	-$30.70M	-$0.19	N/A
Lightbridge	N/A	N/A	-$19.58M	-$0.77	N/A

Emerald has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market. Comparatively, Lightbridge has a beta of 2.14, meaning that its share price is 114% more volatile than the broader market.

Summary

Emerald beats Lightbridge on 7 of the 13 factors compared between the two stocks.

Get Lightbridge News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LTBR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LTBR vs. The Competition

Export

Metric	Lightbridge	Oil, Gas & Consumable Fuels Industry	Energy Sector	NASDAQ Exchange
Market Cap	$289.64M	$11.36B	$9.90B	$12.46B
Dividend Yield	N/A	11.32%	11.58%	10.03%
P/E Ratio	-10.70	19.65	19.40	24.53
Price / Sales	N/A	448.08	367.57	92.60
Price / Cash	N/A	39.42	35.94	46.71
Price / Book	1.32	4.39	3.98	6.07
Net Income	-$19.58M	$5.28B	$4.35B	$348.23M
7 Day Performance	2.74%	1.16%	0.86%	-0.42%
1 Month Performance	-4.63%	4.88%	4.21%	-4.80%
1 Year Performance	-37.00%	34.51%	35.91%	18.61%

Lightbridge Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LTBR Lightbridge	0.068 of 5 stars	$8.24 flat	N/A	-37.0%	$289.64M	N/A	N/A	6	Upcoming Earnings High Trading Volume
OKLO Oklo	3.2092 of 5 stars	$41.88 +4.0%	$88.00 +110.1%	-45.5%	$7.00B	N/A	N/A	78	Upcoming Earnings Gap Up
CRTO Criteo	4.5336 of 5 stars	$20.85 +2.0%	$27.70 +32.9%	-7.1%	$1.03B	$1.94B	9.74	3,649	Upcoming Earnings
GDRX GoodRx	3.4177 of 5 stars	$3.05 +3.0%	$3.81 +25.0%	-32.2%	$1.01B	$796.85M	50.84	950	Positive News Upcoming Earnings
NUTX Nutex Health	4.1917 of 5 stars	$148.70 +1.9%	$243.33 +63.6%	+75.5%	$1.00B	$875.26M	11.49	1,150	Upcoming Earnings Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LTBR) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lightbridge (LTBR) Competitors